Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices
Published Replacement EU Act
This law is a published replacement EU law: Article 13(3a) applies and the Stormont Brake could be used under certain circumstances. Read more about the procedure for new and amending/replacement EU laws and how they apply in Northern Ireland.
The table below sets out the main procedural steps and the work of the Democratic Scrutiny Committee (DSC) in relation to this act.
➡️ Learn more about the terminology and information on this page.
➡️ Learn about the process for published replacement EU acts.
![]() |
Published Replacement EU Act |
![]() |
Article 13(3) |
![]() |
|
|
UK Government Explanatory Memorandum - 14 May 2024 [PDF, 4 Pages, 102KB]
|
|
09/07/2024 |
![]() |
11/07/2024 |
![]() |
18/07/2024 |
![]() |
At its meeting of 18 July 2024, the Committee decided not to hold an inquiry into the replacement EU act. |
![]() |
16/08/2024 |
![]() |
N/A |
![]() |
23/08/2024 |
![]() |
A notification was not received by the Speaker. |
![]() |
N/A |
![]() |
N/A |
![]() |
09/09/2024 |